4-(4-((2,4-Dioxothiazolidin-5-ylidene)methyl)-2-methoxyphenoxy)-3-(trifluoromethyl)benzonitrile

• CAT Number: L032027
• CAS Number: 1055361-35-7
• Molecular Formula: C19H11F3N2O4S
• Molecular Weight: 420.4
• Purity: ≥95%
• IUPAC Name: 4-[4-[(Z)-(2,4-dioxo-1,3-thiazolidin-5-ylidene)methyl]-2-methoxyphenoxy]-3-(trifluoromethyl)benzonitrile
• InChI: InChI=1S/C19H11F3N2O4S/c1-27-15-7-10(8-16-17(25)24-18(26)29-16)2-5-14(15)28-13-4-3-11(9-23)6-12(13)19(20,21)22/h2-8H,1H3,(H,24,25,26)/b16-8-
• InChIKey: OBBIOCQFTMNSJI-PXNMLYILSA-N

4-(4-((2,4-Dioxothiazolidin-5-ylidene)methyl)-2-methoxyphenoxy)-3-(trifluoromethyl)benzonitrile(CAT: L032027) is a complex organic compound often utilized in pharmaceutical and biochemical research. Featuring a unique structure with a thiazolidine ring, a trifluoromethyl group, and a benzonitrile moiety, this compound serves as a valuable intermediate for synthesizing compounds with therapeutic potential. The trifluoromethyl and nitrile groups contribute to its stability, lipophilicity, and potential bioactivity, making it ideal for studies focusing on protein-ligand interactions, metabolic pathway analysis, and drug design targeting enzyme inhibition or receptor modulation. This compound plays an essential role in the exploration of novel agents for applications in oncology, metabolic disorders, and inflammatory conditions.